1997
Incorporation of company, formation of Scientific Advisory Board with Robert Langer, Alex Rich, Jackie Ying, and Elazer Edelman

June, 1998
Operations begun, $1M seed financing from private individuals and the Still River Fund

October, 1999
$2M financing from private individuals, the Still River Fund, and CB Health Ventures

November, 1999
U.S. Genomics receives Phase I SBIR grant for $66,000

November, 1999
U.S. Genomics receives Phase II SBIR grant for $660,000

December, 1999
Addition of Martin Fuchs, VP Engineering, to the company

March, 2000
Addition of Lou Kunkel to the Scientific Advisory Board

August, 2000
Addition of Gordon Wong, Chief Scientific Officer, to the company

November, 2000
Addition of David Bernstein, Esq, Chief Patent Counsel, to the company

April, 2001
$17M financing from HealthCare Ventures, CB Health Ventures, and Still River Fund